On this page
LISSUN raises ₹48 crore to double Sunshine therapy-centre network to 50
Gurugram-based LISSUN raised ₹48 Cr in Series A funding led by Colossa Ventures. It will expand its Sunshine child-development and therapy network from 25 to 50 centres by next year, while investing in AI-led tools and clinical processes.
Store and format facts
Figures from Inc42,
- 10,000+ therapy sessions per month
- ₹45 Cr initially reported funding target
Other figures
- ₹48 Cr ($5 Mn) Series A
What it means for the format
LISSUN’s plan to add 25 Sunshine therapy centres by next year signals accelerating demand for child-development services and raises the bar for scalable, tech-enabled care delivery.
Next on the rollout
- Announcements of city-level centre locations, lease commitments and the opening cadence needed to reach 50 centres by next year.
- Net therapist hiring, attrition, clinician-to-centre ratios and evidence of specialized talent shortages.
- New-centre utilization, appointment wait times, repeat-session rates and centre-level break-even timelines.
- Partnerships with schools, hospitals, pediatric networks, insurers or corporate health-benefit providers.
- Evidence that AI tools reduce administrative time, improve clinical documentation consistency or lift sessions per therapist.
The counter-case
The case against this reading — not reported by the source.
Doubling a therapy-centre network in roughly a year is more an execution and clinician-supply challenge than a capital challenge. ₹48 crore may be insufficient once leases, fit-outs, hiring, therapist training, local marketing and pre-opening losses are accounted for. Rapid expansion could dilute clinical quality, increase therapist churn and create underutilised centres if referral pipelines and paying demand do not scale in tandem. AI-led clinical tooling may add compliance, data-privacy and adoption risks without materially improving unit economics.
The source
First seen